Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris(Massachusetts General Hospital), Mikaël J. Pittet(University of Geneva), Seth B. Garren(Massachusetts General Hospital), Marie Siwicki(Harvard University), Adil Daud(University of California, San Francisco), Rainer H. Köhler(Massachusetts General Hospital), Mai H. Le, Sean P. Arlauckas(Massachusetts General Hospital), Christina Pfirschke(Harvard University), Sara I. Pai(Yale University), Marcel P. Trefny(LMU Klinikum), Ralph Weissleder(Massachusetts General Hospital), Alfred Zippelius(University of Basel), Alain P. Algazi(University of California, San Francisco), Gordon J. Freeman(Dana-Farber Cancer Institute), Cécile Piot(The Francis Crick Institute), Chris Twitty, Sarah Warren(Nanostring Technologies (United States)), Robert H. Pierce(Mabvax Therapeutics (United States)), Camilla Engblom(Karolinska Institutet), Jeremy Gungabeesoon(Harvard University), SuFey Ong(Nanostring Technologies (United States)), Erica Browning
Immunity
December 1, 2018
Cited by 937


Related Papers